Daratumumab in Myeloma Patients With Early or Late Relapse After Initial Therapy: Subgroup Analysis of CASTOR and POLLUX See updated abstract in uploaded … ← Informative Artifacts in AI-Assisted Care. Reply An untapped potential: Curiosity in medical school →